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Background: Korean Red Ginseng (KRG) is a representative traditional herbal medicine with many
different pharmacological properties including anticancer, anti-atherosclerosis, anti-diabetes, and anti-
inﬂammatory activities. Only a few studies have explored the molecular mechanism of KRG-mediated
anti-inﬂammatory activity.
Methods: We investigated the anti-inﬂammatory mechanisms of the protopanaxadiol saponin fraction
(PPD-SF) of KRG using in vitro and in vivo inﬂammatory models.
Results: PPD-SF dose-dependently diminished the release of inﬂammatory mediators [nitric oxide (NO),
tumor necrosis factor-a, and prostaglandin E2], and downregulated the mRNA expression of their cor-
responding genes (inducible NO synthase, tumor necrosis factor-a, and cyclooxygenase-2), without
altering cell viability. The PPD-SF-mediated suppression of these events appeared to be regulated by a
blockade of p38, c-Jun N-terminal kinase (JNK), and TANK (TRAF family member-associated NF-kappa-B
activator)-binding kinase 1 (TBK1), which are linked to the activation of activating transcription factor 2
(ATF2) and interferon regulatory transcription factor 3 (IRF3). Moreover, this fraction also ameliorated
HCl/ethanol/-induced gastritis via suppression of phospho-JNK2 levels.
Conclusion: These results strongly suggest that the anti-inﬂammatory action of PPD-SF could be medi-
ated by a reduction in the activation of p38-, JNK2-, and TANK-binding-kinase-1-linked pathways and
their corresponding transcription factors (ATF2 and IRF3).
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Inﬂammation is an important process because it is one of the
natural defense mechanisms caused by the release of inﬂammatory
mediators [e.g., (nitric oxide) NO and prostaglandin (PG)E2], cyto-
kines [e.g., tumor necrosis factor (TNF)-a], and chemokines [1,2].
This event requires the activation of inﬂammatory cells such as
macrophages via the ligation of their surface receptors (e.g., Toll-gineering, Sungkyunkwan Universi
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phages by ligands derived from pathogens triggers various cellular
signaling cascades to activate transcription factors including nu-
clear factor (NF)-kB (p50 and p65), activator protein (AP)-1 [c-Fos,
c-Jun, and activating transcription factor (ATF)-2], and interferon
regulatory transcription factor (IRF)-3 to trigger the new expression
of inﬂammatory genes [4e6]. Although inﬂammation is a normal
response, acutely, excessive induced, or chronically sustainedty, 2066 Seobu-ro, Suwon 440-746, Korea.
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J Ginseng Res 2015;39:61e6862inﬂammatory responses are known to cause serious diseases
including cancer, stroke, and diabetes. Therefore, it must be
stressed that normalization of upregulated inﬂammation is crucial
in prevention of such diseases [7e9].
Korean Red Ginseng (KRG, steamed root of Panax ginsengMeyer,
Araliaceae) is a well-known herbal medicine traditionally used in
Korea [10]. It has been used for a long time without displaying any
toxic properties, thus, developing some anti-inﬂammatory prepa-
ration with KRG could be considered beneﬁcial. Unlike acid poly-
saccharides that are known as major components contributing to
upregulation of the body’s immune responses [11], red ginseng
saponin fractions enriched with protopanaxadiol (PPD)-type gin-
senosides have been reported as strong anti-inﬂammatory prepa-
rations [12]. Some PPD-type ginsenosides such as ginsenoside (G)-
Rb1, G-Rb2, and G-Rd display strong anti-inﬂammatory properties
under various conditions [13]. This notion led us to establish a
hypothesis that PPD-type saponins could be used as an anti-in-
ﬂammatory remedy. In this study, therefore, we investigated the
anti-inﬂammatory activity and molecular mechanism of the pro-
topanaxadiol saponin fraction (PPD-SF).
2. Materials and methods
2.1. Materials
PPD-SFs, prepared by previously established methods [14], from
KRG with higher amounts of protopanaxadiol-type ginsenosides
(G-Rb1, G-Rc, G-Re, and G-Rb2) were kindly supplied by the Korea
Ginseng Cooperation (Daejeon, Korea). Nu-Nitro-L-arginine methyl
ester hydrochloride (L-NAME), (3-4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), phorbol 12-myristate 13-ac-
etate (PMA), and lipopolysaccharide (LPS, Escherichia coli 0111:B4)
were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
BX795 and SP600125 were obtained from Calbiochem (La Jolla, CA,
USA). Luciferase constructs containing promoters with binding
sites for NF-kB, AP-1, and IRF-3 were used, as reported previously
[15]. RAW264.7 cells, a BALB/c-derived murine macrophage cell
line (ATCC No. TIB-71), and HEK293 cells, a human embryonic
kidney cell line (ATCC No. CRL-1573), were obtained from American
Tissue Culture Collection (Rockville, MD, USA). TANK (TRAF family
member-associated NF-kappa-B activator)-binding kinase (TBK)1
and adaptor molecule [TIR-domain-containing adapter-inducing
interferon-b (TRIF) or myeloid differentiation primary response
gene 88 (MyD88)] were used as reported previously [16]. Fetal
bovine serum and RPMI 1640 were purchased from Gibco (Grand
Island, NY, USA), and phospho-speciﬁc or total antibodies to c-Jun,
c-Fos, ATF-2, IRF-3, extracellular signal-regulated kinase (ERK), p38,
C-Jun N-terminal kinase (JNK), mitogen-activated protein kinase
kinase 4 (MKK4), MKK3/6, transforming growth factor-b-activated
kinase 1 (TAK1), TBK1, lamin A/C, and b-actin were purchased from
Cell Signaling (Beverly, MA, USA). All other chemicals were pur-
chased from Sigma Chemical Co.
2.2. Treatment of PPD-SF
A stock solution (8 mg/mL) of PPD-SF was prepared with culture
medium and diluted to 0e400 mg/mL: with media for in vitro,
cellular assays, or suspended in 1% sodium carboxymethylcellulose
for in vivo experiments.
2.3. Animal experiments
Male imprinting control region (ICR) mice (6e8 weeks old, 17e
21 g) were obtained from Daehan Biolink (Chungbuk, Korea) and
maintained in plastic cages under standard conditions. Water andpelleted food (Samyang, Daejeon, Korea) were supplied ad libitum.
Studies (approval ID: SKKUBBI 13-6-2) were performed in accor-
dance with guidelines established by the Institutional Animal
Care and Use Committee at Sungkyunkwan University, Suwon,
Korea.
2.4. Cell culture
RAW 264.7 and HEK293 cells were cultured in RPMI 1640 me-
dium supplemented with 10% heat-inactivated fetal bovine serum,
glutamine, and antibiotics (penicillin and streptomycin) at 37C
under 5% CO2. For experiments, cells were detached with a cell
scraper. Under our experimental cell density (2  106 cells/mL), the
proportion of dead cells was < 1% according to Trypan blue dye
exclusion tests.
2.5. NO, PGE2, and TNF-a production
After preincubation for 18 hours, RAW264.7 cells (1  106 cells/
mL) were pretreated with PPD-SF (0e400 mg/mL) or the standard
compounds (L-NAME, SP600125, or BX795), and incubatedwith LPS
(1 mg/mL) for 24 hours. The inhibitory effects of PPD-SF or standard
compounds on NO, TNF-a, or PGE2 production were determined by
analyzing the NO, PGE2, or TNF-a levels quantiﬁed with Griess re-
agent, enzyme immunoassay, or enzyme-linked immunosorbent
assay, respectively, as described previously [17,18].
2.6. Cell viability test
After preincubation for 18 hours, PPD-SF (0e400 mg/mL) was
added to RAW264.7 cells (1 106 cells/mL) followed by incubation
for 24 hours. The cytotoxic effects of PPD-SFwere evaluated byMTT
assay, as reported previously [19,20].
2.7. HPLC of PPD-SF
Phytochemical characteristics of PPD-SF with standard ginse-
nosides were identiﬁed by high performance liquid chromatog-
raphy (HPLC) as reported previously [21,22]. The HPLC system was
equipped with a Knauer (Wellchrom, Berlin, Germany) HPLC-pump
K-1001, a Wellchrom fast scanning spectrophotometer K-2600, a
WellChrom UV Detector K-2600, and a four-channel degasser K-
500. Elution solvent (acetonitrile), step gradients (0, 20%, 32%, 50%,
65%, or 90% for 0 minutes, 10 minutes, 40 minutes, 55 minutes, 70
minutes, or 80 minutes, 1.6 mL/minute, 203 nm), and a phenom-
enex gemini C18 ODS (250 mm  4.6 mm, 5 mm) columnwere used.
Based on these conditions, the contents of ginsenosides from PPD-
SF were calculated with the peak area curve of standard
ginsenosides.
2.8. mRNA analysis by quantitative reverse transcriptase-
polymerase chain reaction
To evaluate cytokine mRNA expression levels, RAW264.7 cells
pretreated with PPD-SF (0e400 mg/mL) for 30 minutes were incu-
bated with LPS (1 mg/mL) for 6 hours. Total RNA was isolated with
TRIzol Reagent (Gibco BRL) according to the manufacturer’s in-
structions and stored at 70C until use. The mRNAwas quantiﬁed
by real-time reverse transcriptase polymerase chain reaction (RT-
PCR) with SYBR Premix Ex Taq, according to the manufacturer’s
instructions (Takara, Shiga, Japan), using a real-time thermal cycler
(Bio-Rad, Hercules, CA, USA), as reported previously [23,24]. Results
were expressed as the ratio of the optical density relative to glyc-
eraldehyde 3-phosphate dehydrogenase. The primers used (Bio-
neer, Seoul, Korea) are described in Table 1.
Table 1
Primers used for real-time polymerase chain reaction
Gene name Sequence (50e30)
iNOS F CCCTTCCGAAGTTTCTGGCAGCAG
R GGCTGTCAGAGCCTCGTGGCTTTGG
COX-2 F CACTACATCCTGACCCACTT
R ATGCTCCTGCTTGAGTATGT
TNF-a F TGCCTATGTCTCAGCCTCTTC
R GAGGCCATTTGGGAACTTCT
GAPDH F CACTCACGGCAAATTCAACGGCA
R GACTCCACGACATACTCAGCAC
COX ¼ cyclo-oxygenase; GAPDH ¼ glyceraldehyde 3-phosphate dehydrogenase;
iNOS ¼ inducible NO synthase; TNF ¼ tumor necrosis factor
Y. Yang et al / Protopanaxadiol saponin fraction-mediated anti-inﬂammatory actions 632.9. Plasmid transfection and luciferase reporter gene activity assay
HEK293 cells (1  106 cells/mL) were transfected with 1 mg of
plasmid containing b-galactosidase and NF-kB-Luc, AP-1-Luc, or
IRF-3-Luc in the presence or absence of PMA, or overexpressed
adaptor molecules (TRIF or MyD88) using the polyethylenimine
(PEI) method in 12-well plates. The cells were treated with PPD-SF
for 12 hours prior to termination. Luciferase assays were performed
using the Luciferase Assay System (Promega, Madison, WI, USA), as
previously reported [24,25].0
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Fig. 1. In vitro anti-inﬂammatory activity of PPD-SF in RAW264.7 cells and HPLC analysis of P
RAW264.7 cells treated with LPS (1 mg/mL) in the presence or absence of PPD-SF (left pane
exposure in the absence of LPS was determined by MTT assay. (C) Phytochemical characte
matography. *p < 0.05 compared to the control. **p < 0.01 compared to the control. L-NAME
4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PGE2 ¼ prostaglandin E2; PPD-2.10. Preparation of total lysates and nuclear extracts, and
immunoblotting analysis
Stomach tissues or RAW264.7 cells (5  106 cells/mL) were
washed three times in cold phosphate-buffered saline with 1mM
sodium orthovanadate, and then lysed using a sonicator (Thermo
Fisher Scientiﬁc, Waltham, MA, USA) or a Tissuemizer (Qiagen,
Germantown, MD, USA) in lysis buffer [26] for 30 minutes with
rotation at 4C. Lysates were clariﬁed by centrifugation at
16,000  g for 10 minutes at 4C and stored at 20C until use.
Nuclear fractions were prepared with RAW264.7 cell-derived ly-
sates in a three-step procedure [27]. After treatment, cells were
collected with a rubber policeman, washed with 1  phosphate-
buffered saline, and lysed in 500 mL lysis buffer [28] on ice for 4
minutes. Lysates were centrifuged at 19,326  g for 1 minute in a
microcentrifuge. The pellet (nuclear fraction) was washed once in
washing buffer (lysis buffer without Nonidet P-40) and then treated
with extraction buffer (lysis buffer containing 500mM KCl and 10%
glycerol). The nuclei/extraction buffer mixturewas frozen at80C,
thawed on ice, and centrifuged at 19,326  g for 5 minutes. The
supernatant was collected as a nuclear extract. Soluble cell lysates
(30 mg/lane) were immunoblotted. Either the phosphorylated or
total levels of c-Jun, c-Fos, ATF2, FRA (Fos-related antigen), IRF3,
ERK, p38, JNK, MKK4, MKK3/6, TAK1, TBK1, lamin A/C, and b-actin
were visualized as previously described [29].0
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To evaluate the inhibition of MKK4, MKK6, and MKK7 kinase
activities using puriﬁed enzymes, we used the kinase proﬁler ser-
vice from Millipore (Billerica, MA, USA).
2.12. Ethanol/HCl-induced gastritis
Stomach inﬂammation was induced in mice using HCl/ethanol
according to a published method [30,31]. Fasted ICR mice (7 mice/
group) were orally treated with PPD-SF (200 mg/kg) or ranitidine
(40 mg/kg) twice daily for 3 days. At 30 minutes after the ﬁnal
injection, 400 mL of 60% ethanol in 150mM HCl was administered
orally. Animals were anaesthetized and sacriﬁced with urethane 1
hour after the administration of necrotizing agents. Stomachs
were excised and gently rinsed under running tap water. After
opening the stomachs along the greater curvature and spreading
them out on a board, the area (mm2) of mucosal erosive lesions
was measured using a pixel counter by a technician blinded to the
treatment conditions. Experimental groups included a normal
group (sham-operated/treated with vehicle), control group (HCl/
ethanol injected/treated with vehicle), and drug-treated groups
[HCl/ethanol injected/treated with PPD-SF (200 mg/kg) or raniti-
dine (40 mg/kg)]. Immunoblotting analysis was used to detect the
phosphorylated and total levels of JNK from stomach tissue
lysates.
2.13. Statistical analysis
The data in this paper are presented as the mean  standard
error of the mean of three different experiments performed using
four samples for the in vitro experiments, or as themean standard
deviation for the six mice used in the in vivo tests and the kinase
assay for three samples. For statistical comparisons, these results
were analyzed using analysis of variance/Scheffe’s post hoc and
KruskaleWallis/ManneWhitney tests. A p value < 0.05 was
considered statistically signiﬁcant. All statistical tests were per-
formed using the SPSS 16.0 computer program (SPSS Inc., Chicago,
IL, USA).
3. Results and discussion
To test the anti-inﬂammatory activity of PPD-SF, we ﬁrst used in
vitro inﬂammatory models established with LPS-treated RAW264.7
cells. Under these conditions, we could achieve optimal levels of
NO, PGE2, and TNF- after 24 hours incubation with LPS, as reported
previously [15]. The levels of these inﬂammatory mediators during
LPS exposure were 45mM (NO), 21.6 ng/mL (PGE2), and 6.8 ng/mL
(TNF-a), whereas normal levels of these mediators were below
0.6mM (NO), 0.01 ng/mL (PGE2), and 0.3 ng/mL (TNF-a). As we ex-
pected, PPD-SF (0e400 mg/mL) dose-dependently suppressed the
production of these molecules (Fig. 1A left panel), which shows a
higher activity than those of KRG water extract [32]. In particular,
this fraction more strongly inhibited the release of PGE2, indicating
that this fraction is able to ameliorate more effectively PGE2-
derived pain and inﬂammatory responses. The fact that L-NAME, aFig. 2. Effect of PPD-SF on the transcriptional regulation of inﬂammatory genes in LPS-treate
mL) in the presence or absence of PPD-SF for 6 hours. The mRNA levels of iNOS, TNF-a, and C
constructs (NF-kB-Luc, AP-1-Luc, and IRF-3-Luc) and b-gal (as a transfection control) were
Then, the cells were further incubated with PPD-SF for 12 hours. Luciferase activity was me
factors were identiﬁed by immunoblotting analysis of the lysates of LPS-treated RAW26
AP ¼ activator protein; COX ¼ cyclo-oxygenase; iNOS ¼ inducible NO synthase; IRF ¼ inte
primary response gene 88; NF ¼ nuclear factor; PCR ¼ polymerase chain reaction; PM
TNF ¼ tumor necrosis factor; TRIF ¼ TIR-domain-containing adapter-inducing interferon-b.standard inducible NO synthase inhibitor, diminished NO produc-
tion (Fig. 1A right panel) validates our in vitro inﬂammatory
models. There was no cytotoxicity seen at up to 400 mg/mL PPD-SF
(Fig. 1B), therefore, the inhibitory activity of PPD-SF in in vitro
models could not have been due to its nonspeciﬁc cytotoxicity.
Meanwhile, HPLC analysis showed that this fraction (PPD-SF)
mostly contained G-Rb1 (33.2%), G-Rc (29.4%), G-Rb2 (31.7%), and
G-Rb3 (5.4%) (Fig. 1C), implying that these speciﬁc ginsenosides
could contribute to the mediation of the anti-inﬂammatory activity
of PPD-SF.
To understand the molecular mechanism of PPD-SF-induced
anti-inﬂammatory activity, we next examinedwhether this fraction
inhibited the secretion of inﬂammatory mediators at the tran-
scriptional level. Wemeasured themRNA levels of iNOS, TNF-a, and
cyclo-oxygenase-2 by real-time PCR. Like the upregulation of in-
ﬂammatory mediators, the mRNA levels of their corresponding
genes were also markedly upregulated by LPS, up to 200e1,400-
fold (Fig. 2A), similar to ﬁndings that have been reported previously
[15]. Similarly, PPD-SF strongly decreased the mRNA levels of the
genes in a dose-dependent manner (Fig. 2A). Moreover, the pro-
moter-binding activities of AP-1 and IRF3, but not NF-kB, triggered
by PMA (Fig. 2B, 2E) and adaptor molecules (TRIF and MyD88)
(Fig. 2C, 2D, 2F) were also dose-dependently inhibited by PPD-SF,
indicating that this red ginseng fraction could modulate the tran-
scriptional activation of AP-1 and IRF-3. In agreement with these
results, this fraction suppressed the nuclear translocation of c-Jun
and the phosphorylation of ATF-2 and IRF-3 (Fig. 2G), implying that
the nuclear translocation and phosphorylation events of these
transcription factors could be targeted by PPD-SF. Considering that
red ginseng marc oil was able to block the expression of inﬂam-
matory genes in LPS-treated RAW264.7 cells by suppression of NF-
kB [33], and that Panax notoginseng saponins were also found to
block the NF-kB pathway [34], the pharmacological features of
PPD-SF from KRG seem to be distinctive from those of marc oil and
P. notoginseng saponins. However, because there is still a possibility
that PPD-SF can suppress the activation of NF-kB, we will further
evaluate its potential inhibitory activity under LPS-stimulated
conditions.
Therefore, we further investigated PPD-SF-targeted molecular
events regulating the activation and translocation of AP-1 and IRF-3
in LPS-treated RAW264.7 cells. Previously, it has been reported that
ERK, p38, and JNK are major proteins involved in the regulation of
AP-1 family activation [35]. TBK1 is also regarded as an important
upstream enzyme regulating IRF-3 phosphorylation [4]. PPD-SF
clearly suppressed the phosphorylation of p38 from5minutes to 30
minutes after treatment, and the phosphorylation of JNK at 15e30
minutes after treatment (Fig. 3A), suggesting that these two en-
zymes could be directly or indirectly inhibited by PPD-SF. However,
the upstream enzymes for p38 and JNK phosphorylation were not
inhibited by PPD-SF between 2 minutes and 10 minutes after
treatment (Fig. 3B), whereas the phosphorylation of TBK1, the
phosphorylating enzyme of IRF-3 [4], was suppressed (Fig. 3C).
These results seem to imply that MKK4, MKK6, MKK7, and TBK1
upstream kinase could be directly targeted by this fraction. How-
ever, we did not observe any inhibitory effect of PPD-SF in a direct
enzyme assay performed with puriﬁed MKK4, MKK7, and MKK6,d RAW264.7 cells. (A) RAW264.7 cells (5106 cells/mL) were incubated with LPS (1 mg/
OX-2 were determined by real-time PCR. (BeF) HEK293 cells transfected with plasmid
treated with PMA (100nM) or cotransfected with adaptor molecules (MyD88 or TRIF).
asured using a luminometer. (G) The phospho- or total protein levels of transcription
4.7 cells. *p < 0.05 compared to the control. **p < 0.01 compared to the control.
rferon regulatory factor; LPS ¼ lipopolysaccharide; MyD88 ¼ myeloid differentiation
A ¼ phorbol 12-myristate 13-acetate; PPD-SF ¼ protopanaxadiol saponin fraction;
Fig. 3. Effect of PPD-SF on the upstream signaling activation of AP-1 and IRF-3 pathways. (AeC) RAW264.7 cells were incubated with LPS (1mg/mL) in the presence or absence of
PPD-SF for the indicated times. Total or phospho-levels of ERK, p38, JNK, MKK4, MKK3/6, TAK1, and TBK1 in whole lysates were determined by immunoblotting analysis. (D) Effects
of PPD-SF on the kinase activities of MKK4, MKK7, and MKK6 were determined by direct enzyme assays. (E) PGE2 inhibitory activities of SP600125 and BX795 were determined by
Griess assay and EIA. *p < 0.05 compared to the control. **p < 0.01 compared to the control. AP ¼ activator protein; COX ¼ cyclo-oxygenase; ERK ¼ extracellular signal-regulated
kinase; iNOS ¼ inducible NO synthase; IRF ¼ interferon regulatory factor; JNK ¼ C-Jun N-terminal kinase; LPS ¼ lipopolysaccharide; MKK ¼ mitogen-activated protein kinase
kinase; PGE2 ¼ prostaglandin E2; PPD-SF ¼ protopanaxadiol saponin fraction; TAK ¼ transforming growth factor-b-activated kinase 1; TBK ¼ TNAK-binding kinase.
J Ginseng Res 2015;39:61e6866indicating that these enzymes are not targets of PPD-SF. Moreover,
we could not test the upstream TBK1-phosphorylating enzyme,
because the TBK1-phosphorylating enzymes have not yet been
identiﬁed [36]. Therefore, we will continue to identify targets
speciﬁcally inhibited by PPD-SF for the suppression of AP-1 and
IRF-3 pathways. Meanwhile, the inhibitory activities of SP600125, a
JNK inhibitor, and BX795, a TBK1 inhibitor, on the production of
PGE2 (Fig. 3E) strongly suggested the critical involvement of these
enzymes in the inﬂammatory process. Other research groups have
also found that the enzymes, JNK and TBK1, play important path-
ological roles in many different inﬂammatory responses and
symptoms, such as colitis [37e39].To develop a strong and safe anti-inﬂammatory remedy, deter-
mining whether the preparation is orally active in an in vivomodel
is critical. Although orally administered KRG-water extract is re-
ported to have anti-inﬂammatory activity in a mouse inﬂammation
model with allergic rhinitis [40], whether PPD-SF is able to
ameliorate in vivo inﬂammatory symptoms was examined using a
HCl/ethanol-induced mouse gastritis model. As Fig. 4A shows, PPD-
SF strongly suppressed the formation of gastric ulcer triggered by
HCl/ethanol. In particular, it was also revealed that the level of
phospho-JNK2 was markedly decreased by PPD-SF, according to
immunoblotting analysis with stomach lysates (Fig. 4B). Therefore,
these results also strongly suggest that PPD-SF can be an orally
Fig. 4. In vivo anti-inﬂammatory activity of PPD-SF. (A) Mice were orally administered PPD-SF (200 mg/kg) or ranitidine (40 mg/kg) for 3 days and were then orally treated with HCl/
ethanol. After 1 hour, gastric stomach lesions were measured with a ruler (right panel), and photographs were taken (left panel). Gastric lesions formed after treatment with inducer
alone were set as 100%. (B) Stomachs prepared from HCl/ethanol-treated mice preadministered with PPD-SF were lysed with lysis buffer. Total or phospho-levels of JNK and b-actin
were determined by immunoblotting analysis. *p < 0.05 compared to the control. JNK ¼ C-Jun N-terminal kinase; PPD-SF ¼ protopanaxadiol saponin fraction.
Y. Yang et al / Protopanaxadiol saponin fraction-mediated anti-inﬂammatory actions 67effective anti-inﬂammatory preparation with JNK inhibitory
properties.
In summary, we found that PPD-SF is capable of diminishing in
vitro inﬂammatory responses mediated by macrophage-like
RAW264.7 cells treated with LPS and suppressing in vivo gastritis
symptoms induced by HCl/ethanol in mice. Through the analysis of
transcription factors and their upstream signaling enzymes, it was
demonstrated that c-Jun, ATF-2, and IRF-3 and their upstream
activation pathways including p38, JNK, and TBK1 could be targeted
by PPD-SF, as summarized in Fig. 5. Therefore, our results strongly
suggest that PPD-SF can be developed as a KRG-derived anti-in-
ﬂammatory remedy.TLR4
LPS
MyD88
AP-1
NO PGE2
c-Jun
COX-2iNOS
TRIF
ATF2
p38TBK1
IRF3
TNF-α
JNK
TNF-α
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Fig. 5. The putative inhibitory pathway of PPD-SF-mediated anti-inﬂammatory re-
sponses. PPD-SF ¼ protopanaxadiol saponin fraction.Conﬂicts of interest
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